Log In
Print this Print this

Gemzar, gemcitabine

  Manage Alerts
Collapse Summary General Information
Company Eli Lilly and Co.
DescriptionNucleoside analog
Molecular Target Ribonucleotide reductase ; DNA polymerase
Mechanism of ActionDNA synthesis inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today